Search

everythinglearnresearchcommunity

for

Search:↓

Managing multiple autoimmune diseases in one patient is very challenging.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Methotrexate plus prednisolone had the fewest serious side effects.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Visual field defects in lupus nephritis can be caused by hypertensive retinopathy, not glaucoma or medication toxicity.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.